Kymera Therapeutics, Inc. SEC filings KYMR
Kymera Therapeutics, Inc. has 647 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 25, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 8, 2026 | Jun 5, 2026 |
| 10-Q | Quarterly report | Apr 30, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2026 | Apr 30, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 27, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Other events
|
Feb 26, 2026 | Feb 26, 2026 |
| 424B3 | Prospectus | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 10, 2025 | Dec 8, 2025 |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| 424B5 | Prospectus supplement | Dec 8, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 3, 2025 | Aug 27, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 27, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2025 | Jun 25, 2025 |
| 424B5 | Prospectus supplement | Jun 27, 2025 | — |
| 424B5 | Prospectus supplement | Jun 25, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2025 | May 9, 2025 |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 25, 2025 |
| UPLOAD | Letter from the SEC | Apr 25, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2025 | Mar 3, 2025 |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 14, 2025 | Jan 14, 2025 |
| S-3ASR | Automatic shelf registration | Oct 31, 2024 | — |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 20, 2024 | Aug 19, 2024 |
| 424B5 | Prospectus supplement | Aug 20, 2024 | — |
| 424B5 | Prospectus supplement | Aug 19, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2024 | Jun 18, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2024 | Mar 28, 2024 |
| S-8 | Employee stock plan registration | Feb 22, 2024 | — |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jan 5, 2024 | Jan 4, 2024 |
| 424B5 | Prospectus supplement | Jan 5, 2024 | — |
| 424B5 | Prospectus supplement | Jan 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 2, 2023 | Nov 2, 2023 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 22, 2023 | May 22, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2023 | Feb 27, 2023 |
| S-8 | Employee stock plan registration | Feb 23, 2023 | — |
| 10-K | Annual report | Feb 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 14, 2022 | Dec 14, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 3, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 13, 2022 | Oct 13, 2022 |
| 424B3 | Prospectus | Sep 6, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 19, 2022 | Aug 19, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2022 | Jun 15, 2022 |
| 10-Q | Quarterly report | May 3, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 3, 2022 | May 3, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 11, 2022 | Apr 6, 2022 |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| 10-K | Annual report | Feb 24, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2022 | Jan 17, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 27, 2021 | Dec 20, 2021 |
| 8-K |
Current report
Other events
|
Dec 16, 2021 | Dec 16, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 27, 2021 | Oct 27, 2021 |
| S-3ASR | Automatic shelf registration | Oct 1, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2021 | Sep 16, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2021 | Aug 6, 2021 |
| 424B4 | Prospectus | Jul 2, 2021 | — |
| EFFECT | Filing | Jun 30, 2021 | — |
| S-1MEF | Filing | Jun 30, 2021 | — |
| CORRESP | Letter to the SEC | Jun 28, 2021 | — |
| CORRESP | Letter to the SEC | Jun 28, 2021 | — |
| S-1 | Registration statement | Jun 28, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 28, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2021 | Jun 16, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| UPLOAD | Letter from the SEC | Mar 19, 2021 | — |
| DRS | Filing | Mar 17, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Mar 16, 2021 | Mar 12, 2021 |
| S-8 | Employee stock plan registration | Mar 11, 2021 | — |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2021 | Mar 11, 2021 |
| SEC STAFF LETTER | Filing | Mar 11, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 2, 2021 | Mar 2, 2021 |
| SEC STAFF LETTER | Filing | Feb 10, 2021 | — |
| 8-K |
Current report
Results of operations
|
Jan 12, 2021 | Jan 12, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2020 | Sep 4, 2020 |
| 8-K |
Current report
Material agreement
|
Sep 1, 2020 | Aug 27, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 25, 2020 | Aug 20, 2020 |
| S-8 | Employee stock plan registration | Aug 21, 2020 | — |
| 424B4 | Prospectus | Aug 21, 2020 | — |
| EFFECT | Filing | Aug 20, 2020 | — |
| S-1MEF | Filing | Aug 20, 2020 | — |
| CERT | 8a cert | Aug 20, 2020 | — |
| 8-A12B | Filing | Aug 18, 2020 | — |
| CORRESP | Letter to the SEC | Aug 18, 2020 | — |
| CORRESP | Letter to the SEC | Aug 18, 2020 | — |
| S-1/A | Amended registration statement | Aug 17, 2020 | — |
| CORRESP | Letter to the SEC | Aug 13, 2020 | — |
| S-1/A | Amended registration statement | Aug 13, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2020 | — |
| CORRESP | Letter to the SEC | Aug 5, 2020 | — |
| S-1/A | Amended registration statement | Aug 5, 2020 | — |
| CORRESP | Letter to the SEC | Jul 31, 2020 | — |
| S-1 | Registration statement | Jul 31, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2020 | — |
| DRS | Filing | Jun 22, 2020 | — |
Showing 168 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KYMR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Watertown, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1815442
- Former names
- Kymera Therapeutics, Inc. (until Oct 29, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.